Bromocriptine-responsive akinetic mutism following endoscopy for ventricular neurocysticercosis: Case report and review of the literature

Journal of Neurosurgery

Volumn 99, Issue 2, 2003, Pages 397-401

  Psarros, Thomas G ^a   Zouros, Alexander ^a   Coimbra, Caetano ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Bromocriptine; Dopaminergic agonist; Hydrocephalus; Mutism

Indexed keywords

ALBENDAZOLE; BROMOCRIPTINE;

ADULT; AKINETIC MUTISM; ANASTOMOSIS; ARTICLE; BEHAVIOR; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DOPAMINERGIC SYSTEM; ENDOSCOPIC SURGERY; ENDOSCOPY; FEMALE; HEADACHE; HUMAN; HYDROCEPHALUS; LETHARGY; NEUROCYSTICERCOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PAPILLEDEMA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RISK FACTOR; SYMPTOM; VISUAL IMPAIRMENT;

EID: 0041343265     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.2003.99.2.0397     Document Type: Article

References (52)

1. Abekura M: Akinetic mutism and magnetic resonance imaging in obstructive hydrocephalus. Case illustration. J Neurosurg 88:161, 1998
2. Ackermann H, Ziegler W: Akinetischer Mutismus-eine Literaturubersicht. Fortschr Neurol Psychiatry 63:52-67, 1995
3. Aidi S, Elalaoui-Faris M, Benabdeljlil M, et al: Mutisme akinetique et pseudo-paralysie supranucleaire progressive secondaires a laderivation d'une hydrocephalie obstructive. Effect benefique de la bromocriptine: 2 cas. Rev Neurol 156:380-383, 2000
4. Akhtar S, Buckman J: The differential diagnosis of mutism: a review and report of three unusual cases. Dis Nerv Syst 38:558-563, 1977
5. Alexander MP: Chronic akinetic mutism after mesencephalicdiencephalic infarction: remediated with dopaminergic medications. Neurorehabil Neural Repair 15:151-156, 2001
6. Alves AM, Ceballos R: The syndrome(s) of akinetic mutism. Extent of the concept based on clinical, anatomical and physiopathological grounds. Int Surg 56:392-401, 1971
7. Anderson B: Relief of akinetic mutism from obstructive hydrocephalus using bromocriptine and ephedrine. Case report. J Neurosurg 76:152-155, 1992
8. Barris RW, Schuman HR: Bilateral anterior cingulate gyrus lesions. Syndrome of the anterior cingulate gyri. Neurology 3:44-52, 1953
9. Berger L, Gauthier S, Leblanc R: Akinetic mutism and parkinsonism associated with obstructive hydrocephalus. Can J Neurol Sci 12:255-258, 1985
10. Cairns H, Oldfield RC, Pennybacker JB, et al: Akinetic mutism with an epidermoid cyst of the 3rd ventricle. With a report on the associated disturbance of brain potentials. Brain 64:273-290, 1941
11. Combarros O, Infante J, Berciano J: Akinetic mutism from frontal lobe damage responding to levodopa. J Neurol 247:568-569, 2000
12. Crismon ML, Childs A, Wilcox RE, et al: The effect of bromocriptine on speech dysfunction in patients with diffuse brain injury (akinetic mutism). Clin Neuropharmacol 11:462-466, 1988
13. Daly DD, Love JG: Akinetic mutism. Neurology 8:238-242, 1958
14. Devinsky O, Morrell MJ, Vogt BA: Contributions of anterior cingulate cortex to behavior. Brain 118:279-306, 1995
15. Dobkin BH, Hanlon R: Dopamine agonist treatment of antegrade amnesia from a mediobasal forebrain injury. Ann Neurol 33:313-316, 1993
16. Duma D, Argintaru D, Serban M: Tumoare mezodiencefalica cu mutism akinetic. Neurol Psihiatr Neurochir 12:201-205, 1967
17. Echiverri HC, Tatum WO, Merens TA, et al: Akinetic mutism: pharmacologic probe of the dopaminergic mesencephalofrontal activating system. Pediatr Neurol 4:228-230, 1988
18. Fessenmeier JT, Kuzniecky R, Garcia JH: Akinetic mutism caused by bilateral anterior cerebral tuberculous obliterative arteritis. Neurology 40:1005-1006, 1990
19. Freemon FR: Akinetic mutism and bilateral anterior cerebral artery occlusion. J Neurol Neurosurg Psychiatry 34:693-698, 1971
20. Gugliotta MA, Silvestri R, De Domenico P, et al: Spontaneous bilateral anterior cerebral artery occlusion resulting in akinetic mutism. A case report. Acta Neurol 11:252-258, 1989
21. Kadota Y, Kondo T, Sato K: Akinetic mutism and involuntary movements following radical resection of hypothalamic gliomacase report. Neurol Med Chir 36:447-450, 1996
22. Karli DC, Burke DT, Kim HJ, et al: Effects of dopaminergic combination therapy for frontal lobe dysfunction in traumatic brain injury rehabilitation. Brain Injury 13:63-68, 1999
23. Lechavalier B, Bertran F, Busson P, et al: Mutisme akinetique avec hemiplegie droite par infarctus du territoire de l'artere cerebrale anterieure gauche. Rev Neurol 152:181-189, 1996
24. Lin KL, Wang HS, Chou ML, et al: Role of cavum septum pellucidum in akinetic mutism of hydrocephalic children. Pediatr Neurol 16:156-159, 1997
25. Mackintosh TF: Akinetic mutism following coal-gas poisoning with subsequent recovery. Postgrad Med J 41:567-573, 1965
26. Mann MW, Degas JD: Akinetic mutism in Wernicke-Korsakoff disease: a case report. J Neurol Neurosurg Psychiatry 51:588-590, 1988
27. McDowell S, Whyte J, D'Esposito M: Differential effects of a dopaminergic agonist on prefrontal function in traumatic brain injury patients. Brain 121:1155-1164, 1998
28. Mega MS, Cohenour RC: Akinetic mutism: disconnection of frontal-subcortical circuits. Neuropsychiatry Neuropsychol Behav Neurol 10:254-259, 1997
29. Messert B, Henke TK, Langheim W: Syndrome of akinetic mutism associated with obstructive hydrocephalus. Neurology 16:635-649, 1966
30. Minderhoud JM, van Woerkom TC, van Weerden TW: On the nature of brain stem disorders in severe head injured patients. II. A study on caloric vestibular reactions and neurotransmitter treatment. Acta Neurochir 34:23-25, 1976
31. Mochizuki H, Saito H: Mesial frontal lobe syndromes: correlations between neurological deficits and radiological localizations. Tohoko J Exp Med 161 (Suppl):231-239, 1990
32. Moolten SE: Syndrome of profound apathy (akinetic mutism) secondary to thalamic metastasis of unrecognized lung cancer. Mt Sinai J Med 39:76-81, 1972
33. Moser A, Freyberger HJ, Bruckman H, et al: Akinetischer Mutisms bei dekompensiertem triventrikularen Hydrozephalus. Fortsch Neurol Psychiatry 63:248-251, 1995
34. Muller U, Von Cramon DV: The therapeutic potential of bromocriptine in neuropsychological rehabilitation of patients with acquired brain damage. Prog Neuropsychopharmacol Biol Psychiatry 18:1103-1120, 1994
35. Nemeth G, Hegedus K, Molnar L: Akinetic mutism associated with bicingular lesions: clinicopathological and functional anatomical correlates. Eur Arch Psychiatry Neurol Sci 237:218-222, 1988
36. Nicolai J, Van Putten MJ, Tavy DL: BIPLEDs in akinetic mutism caused by bilateral anterior cerebral artery infarction. Clin Neurophysiol 112:1726-1728, 2001
37. Oberndorfer S, Urbanits S, Lahrmann H, et al: Akinetic mutism caused by bilateral infiltration of the fornix in a patient with astrocytoma. Eur J Neurol 9:311-313, 2002
38. Park-Matsumoto YC, Ogawa K, Tazawa T, et al: Mutism developing after bilateral thalamo-capsular lesions by neuro-Behcet disease. Acta Neurol Scand 91:297-301, 1995
39. Ross ED, Steward RM: Akinetic mutism from hypothalamic damage: successful treatment with dopamine agonists. Neurology 31:1435-1439, 1981
40. Rossitch E Jr, Bullard DE: The autonomic dysfunction syndrome: aetiology and treatment. Br J Neurosurg 2:471-478, 1988
41. Scott TF, Lang D, Girgis RM, et al: Prolonged akinetic mutism due to multiple sclerosis. J Neuropsychiatry Clin Neurosci 7:90-92, 1995
42. Skultety FM: Clinical and experimental aspects of akinetic mutism. Report of a case. Arch Neurol 19:1-14, 1968
43. Stewart JT: Akathisia following traumatic brain injury: treatment with bromocriptine. J Neurol Neurosurg Psychiatry 52:1200-1201, 1989 (Letter)
44. Stewart JT, Leadon M, Gonzalez-Rothi RJ: Treatment of a case of akinetic mutism with bromocriptine. J Neuropsychiatry Clin Neurosci 2:462-463, 1990 (Letter)
45. Stuss DT, Benson DF: Neuropsychological studies of the frontal lobes. Psychol Bull 95:3-28, 1984
46. Ungerstedt U: Functional dynamics of central monoamine pathways, in Schmitt FO, Worden FG (eds): The Neurosciences Third Study Program. Cambridge, MA: MIT Press, 1974, pp 979-988
47. Van Domburg PH, ten Donkelaar HJ, Notermans SL: Akinetic mutism with bithalamic infarction. Neurophysiological correlates. J Neurol Sci 139:58-65, 1996
48. Van Woerkom TC, Teelken AW, Minderhous JM: Difference in neurotransmitter metabolism in frontotemporal-lobe contusion and diffuse cerebral contusion: Lancet 1:812-813, 1977 (Letter)
49. Vecht CJ, van Woerkom CA, Teelkan AW, et al: Homovanillic acid and 5-hydroxyindoleacetic acid cerebrospinal fluid levels. A study with and without probenecid administration of their relationship to the state of consciousness after head injury. Arch Neurol 32:792-797, 1975
50. Watahiki Y, Narita S, Kurahashi K, et al: [Akinetic mutism from recurrent hydrocephalus: successful treatment with levodopa, bromocriptine, and trihexyphenidyl.] No To Shinkei 39:977-982, 1987 (Jpn)
51. Weiner N: Norepinephrine, epinephrine, and sympathomimetic amines, in Goodman LS, Gilman AG, Rall TW, et al (eds): Goodman and Gilman's The Pharmacological Basis of Therapeutics, ed 7. New York: Macmillan, 1985, pp 145-180
52. Wolff V, Sainte Maurice JP, Ducros A, et al: Mutisme akinetique et infarctus bicerebral anterieur par anomalie de distribution de l'artere cerebrale anterieure. Rev Neurol 158:377-380, 2002